Bernstein initiates Neurocrine stock with outperform rating on drug potential

Bernstein initiates Neurocrine stock with outperform rating on drug potential

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.